Coral Laboratories has considered and approved its Cost Audit Report for the financial year 2025-26. The decision was taken during a board meeting held on Friday, September 25, 2026.

The company notified BSE Limited regarding the outcome of the meeting pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Previously, the company had intimated the exchange about the scheduled meeting under Regulation 29 on September 21, 2026.

Meeting Outcome

The Board of Directors transacted the following business during the session:

• Considered and approved Cost Audit Report in CRA-3 format for the financial year 2025-26
• Any other business with the permission of the chairman

The meeting commenced at 2:30 pm and concluded at 2:58 pm. Sushma Kadkade, Director and CFO, signed the outcome intimation on September 25, 2026.

Coral Laboratories has scheduled its 44th Annual General Meeting for September 29, 2026. The company intends to propose a final dividend of ₹2.00 per equity share for the financial year ending March 31, 2026.

The meeting will be conducted through video conferencing or other audio-visual means in compliance with Ministry of Corporate Affairs circulars. Shareholders can participate remotely to transact the business set out in the notice.

Dividend and Book Closure Details

The Register of Members and transfer books will remain closed from September 23, 2026, to September 29, 2026. This closure is to ascertain the list of members entitled to receive the proposed dividend.

Eligibility is determined by names appearing in the beneficial owner list furnished by depositories or the register of members as of the end of business hours on Tuesday, September 22, 2026.

Payment and Tax Implications

Dividend payments will be made electronically after September 30, 2026. The company mandates using bank account details furnished by depositories or maintained by the Registrar and Transfer Agent. Tax at source will be deducted as per the Finance Act, 2025. Members are requested to submit necessary documents by September 18, 2026, to determine the appropriate tax rate.

Financial Performance

For FY26, Coral Laboratories reported income of ₹9,579.68 lakh, down from ₹12,411.39 lakh in FY25. Earnings after tax stood at ₹1,683.13 lakh, compared to ₹2,415.56 lakh in the previous year. Exports decreased to ₹7,707.14 lakh from ₹9,382.14 lakh.

What the Numbers Show

The proposed dividend payout represents a 20% yield on the ₹10 face value of the equity shares. This indicates a consistent return mechanism for shareholders holding physical or demat shares as of the record date, despite the decline in operational revenue and profit.